Researcher
Joris Delanghe
- Keywords:laboratory medicine
- Disciplines:Proteins, General diagnostics, Carbohydrates
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Clinical chemistry, microbiology and immunology (Department)
Responsible
From1 Oct 2017 → 30 Sep 2018 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Oct 2017 → 30 Sep 2018 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Feb 1994 → 30 Sep 2018
Projects
1 - 6 of 6
- A non-invasive topical scar treatment for deep burn victimsFrom15 Apr 2021 → 31 Dec 2023Funding: IOF - technology validation in lab
- Non-surgical treatment of Cataract for animal and human applicationFrom1 Jun 2020 → 15 Oct 2023Funding: IOF - technology validation in lab
- Enzymatic treatment for age-related macular degeneration and excessive burn scarsFrom15 Oct 2018 → 31 May 2021Funding: IOF - technology validation in real environment
- Direct Infrared Analysis of Keratin GlycationFrom1 Oct 2016 → 7 Nov 2018Funding: IOF - Industrial Research Fund
- Unraveling the natural isotopic fractionation of Fe accompanying different homeostatic processes for understanding the effect of impaired Fe regulation on its isotopic composition in biological fluids.From1 Oct 2015 → 30 Sep 2018Funding: BOF - Other initiatives
- Study of glycated protein as a marker for diabetes in Central AfricaFrom1 Oct 2013 → 30 Sep 2017Funding: BOF - Doctoral projects
Publications
1 - 10 of 112
- Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children(2024)
Authors: Evelyn Dhont, Tatjana Van Der Heggen, Evelien Snauwaert, Jef Willems, Siska Croubels, Joris Delanghe, Jan De Waele, Roos Colman, Johan Vande Walle, Peter De Paepe, et al.
Pages: 1607 - 1616 - The genetic legacy of the expansion of Bantu-speaking peoples in Africa(2024)
Authors: Cesar A. Fortes-Lima, Concetta Burgarella, Rickard Hammarén, Anders Eriksson, Mário Vicente, Cecile Jolly, Armando Semo, Hilde Gunnink, Sara Pacchiarotti, Leon Mundeke, et al.
Pages: 540 - 547 - About the estimation of albuminuria based on proteinuria results(2023)
Authors: Joris Delanghe, Matthijs Oyaert, Marc De Buyzere, Marijn Speeckaert
Pages: E1 - E2 - Treatment of hypertrophic scars with corticoid-embedded dissolving microneedles(2023)
Authors: Ignace De Decker, Anna Szabó, Hendrik Hoeksema, Marijn Speeckaert, Joris Delanghe, Phillip Blondeel, Sandra Van Vlierberghe, Stan Monstrey, Karel Claes
Pages: 158 - 169 - Pitfalls in the diagnosis of hematuria(2023)
Authors: Joris Delanghe, Marijn Speeckaert, Sigurd Delanghe, Matthijs Oyaert
Pages: 1382 - 1387 - C-reactive protein interacts with amphotericin B liposomes and its potential clinical consequences(2023)
Authors: Joris Delanghe, Jonas Himpe, Jerina Boelens, Dominique Benoit, Bram Gadeyne, Marijn Speeckaert, Frederick Verbeke
Pages: 1065 - 1068 - Glucosuria and interference of urinary albumin-to-creatinine ratio(2023)
Authors: Joris Delanghe, Matthijs Oyaert, Marc De Buyzere, Sigurd Delanghe, Marijn Speeckaert
Pages: 201 - 201 - ACE polymorphism is a determinant for COVID-19 mortality in the post-vaccination era(2022)
Authors: Joris Delanghe, Marijn Speeckaert, Marc De Buyzere
Pages: E32 - E33 - A tissue section-based near-infrared spectroscopical analysis of salivary gland tumors(2021)
Authors: Renaat Coopman, Sander De Bruyne, Marijn Speeckaert, Tijl Vermassen, Hubert Vermeersch, David Creytens, Joris Delanghe
- The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome(2021)
Authors: Mieke Steenbeke, Sander De Bruyne, Marc De Buyzere, Bruno Lapauw, Reinhart Speeckaert, Mirko Petrovic, Joris Delanghe, Marijn Speeckaert
Pages: 113 - 130
Patents
1 - 6 of 6
- Compositions for use to treat advanced glycation end products-dependent ocular diseases (Inventor)
- Compositions for use to treat cataract (Inventor)
- Compositions for use to treat advanced glycation end products-dependent ocular diseases (Inventor)
- Compositions for use to treat cataract (Inventor)
- DIRECT INFRARED ANALYSIS OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS (Inventor)
- DIRECT INFRARED ANALYSIS OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS (Inventor)